Cognitive Care
Commercial- Indications
- Cognitive enhancement
Company intelligence / Profile preview
Disruption Labs has developed a proprietary plant-based nano-delivery technology that enhances the efficacy and stability of active ingredients in food/beverage/nutraceutical/cosmetic/pet nutrition markets. Their solutions address challenges such as poor solubility and shelf-stability. The company partners with brands to develop new or improved consumer health products using their patented tech. They have been validated by multinational companies in the $630B+ nutraceutical market but do not appear to have published clinical trial results typical of pharma biotech firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Disruption Labs.